The 2021 OHDSI Symposium will include two plenary sessions. Below are details on each one.
The first plenary will be held Tuesday, Sept. 14, beginning at 8 am ET, and it will have an extended community discussion about the COVID-19 pandemic and the work that the OHDSI community has played in advancing the science through methodological research as well as the clinical impact of the work to date. It will then have a distinguished panel to react to the content and provide perspective on directions where we can all move forward together.
The session will start at with the State of the Community address by George Hripcsak. We will also hear updates about OHDSI’s US Network from Kristin Kostka, European efforts from Peter Rijnbeek, and progress from our Asia-Pacific community from Mui Van Zandt.
At 9 am ET, there will have series of presentations on Methods Research for COVID-19, across our community’s primary analytic use cases of Characterization, Estimation, and Prediction:
• Anna Ostropolets will present on evaluating incidence rate sensitivity and the impact of anchoring.
• Rupa Makadia will present findings on the sensitivity of incidence rates to phenotype algorithm choices.
• Martijn Schuemie will provide an overview and showcase main results from the EUMAEUS project: a methods evaluation of vaccine surveillance approaches.
• Faaizah Arshad will highlight a particularly important finding from EUMAEUS: the performance when applying methods sequentially.
• Jenna Reps will present progress on developing large-scale prediction models and the impact of applying a model trained in one context to other.
At 10 am ET, there will be a series of presentations on OHDSI’s clinical impact during the COVID-19 pandemic:
• Seng Chan You will highlight prior published work by the community during the early part of the pandemic
• Talita Duarte-Salles will review the progress and results from the CHARYBDIS project: a large-scale characterization of COVID disease natural history.
• Albert Prats-Uribe will showcase characterization of drug utilization patterns amongst COVID patients.
• Xintong Li will discuss the impact of OHDSI’s work in characterizing background rates of COVID vaccine adverse events of special interest.
• Marc Suchard will highlight lessons learned in the SCYLLA project: a large-scale population-level effect estimation study to examine potential repurposed COVID therapeutics.
• George Hripcsak will introduce the latest research into using electronic health record data to study vaccine effectiveness.
At 11 am ET, we will have a reaction panel, moderated by Dani Prieto-Alhambra, with a distinguished panel that includes Catherine Cohet, Richard Forshee, Magdalena Sobieszczyk and Joanne Waldstreicher.
There will be two ways to join the Plenary session:
1 – The meeting will take place as a MSTeams Webinar. You will receive a calendar invitation with a link if you registered. Click on the link and you will join the meeting as an attendee. As an attendee, you will be able to ask questions of the presenters and panelists by typing into the Chat feature.
2 – For those who would like to interact with others while watching the presentations, you can enter into the Gather.Town virtual world that has been created for the OHDSI2021 Symposium. You will see viewing lounges with couches and TVs to watch the webinar. Further details on Gather.Town will be posted as part of the Collaborator Showcase.